Impact of pharmaceutical care on the quality of life of patients with heart failure due to chronic Chagas disease: Randomized clinical trial

Por Chambela, Mayara da Costa, Mediano, Mauro Felippe Felix, Carneiro, Fernanda Martins, Ferreira, Roberto Rodrigues, Waghabi, Mariana Caldas, Mendes, Verônica Gonçalves, Oliveira, Luciano de Souza, de Holanda, Marcelo Teixeira, de Sousa, Andréa Silvestre, da Costa, Andréa Rodrigues, Xavier, Sérgio Salles, da Silva, Gilberto Marcelo Sperandio, Saraiva, Roberto Magalhães
Publicado no Br J Clin Pharmacol (2019)

TGF-β Polymorphisms Are a Risk Factor for Chagas Disease

Por Ferreira, Roberto Rodrigues, Madeira, Fabiana da Silva, Alves, Gabriel Farias, Chambela, Mayara da Costa, Curvo, Eduardo de Oliveira Vaz, Moreira, Aline dos Santos, Almeida de Sá, Renata, Mendonça-Lima, Leila, Cabello, Pedro Hernan, Bailly, Sabine, Feige, Jean-Jacques, Araujo-Jorge, Tania Cremonini, Saraiva, Roberto Magalhães, Waghabi, Mariana Caldas
Publicado no Dis Markers (2018)

TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas’ heart disease

Por Ferreira, Roberto Rodrigues, Abreu, Rayane da Silva, Vilar-Pereira, Glaucia, Degrave, Wim, Meuser-Batista, Marcelo, Ferreira, Nilma Valéria Caldeira, da Cruz Moreira, Otacílio, da Silva Gomes, Natália Lins, Mello de Souza, Elen, Ramos, Isalira P., Bailly, Sabine, Feige, Jean-Jacques, Lannes-Vieira, Joseli, de Araújo-Jorge, Tania C., Waghabi, Mariana Caldas
Publicado no PLoS Negl Trop Dis (2019)